Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the answer of 24 November 2025 to question 91186, what steps he will take to engage with BSL signers to assess the suitability of products which use Artificial Intelligence approaches to British Sign Language.

The Department is aware of a number of emerging products that use artificial intelligence (AI) to support translation into British Sign Language (BSL). While the Department and its arm’s‑length bodies are not currently developing or deploying such tools, any AI‑enabled BSL product proposed for use in the National Health Service would be subject to the medical device regulatory framework and will be assessed to determine whether it falls with the scope of regulations. These regulations are underpinned by rigorous standards established by bodies including the Medicines and Healthcare products Regulation Agency, the National Institute for Health and Care Excellence, the Health Research Authority, and the Care Quality Commission. These agencies ensure that AI technologies are safe, effective, and cost-effective within healthcare settings.

For any BSL products that use AI, meaningful engagement with BSL signers and Deaf communities is critical. This includes ensuring that proposed products provide a high quality service, meet communication needs identified through the Accessible Information Standard, and reflect the lived experience of BSL users. NHS England continues to work with stakeholders, including BSL users, providers, and representative groups, to improve accessibility and to understand where emerging technologies may safely and effectively support communication.